血清甲胎蛋白联合维生素K缺乏或拮抗剂Ⅱ诱导蛋白在肝细胞癌病理诊断中的应用价值

鹿宁宁; 张英华; 王海燕; 高文峰; 郑加生

doi:10.3969/j.issn.1001-5256.2017.11.022

血清甲胎蛋白联合维生素K缺乏或拮抗剂Ⅱ诱导蛋白在肝细胞癌病理诊断中的应用价值

DOI: 10.3969/j.issn.1001-5256.2017.11.022

首都医科大学附属北京佑安医院肿瘤微创介入中心

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2043
- HTML全文浏览量: 42
- PDF下载量: 378
- 被引次数: 0
出版历程
- 收稿日期: 2017-07-19
- 出版日期: 2017-11-20

Value of serum alpha-fetoprotein and protein induced by vitamin K absence or antagonist-Ⅱ in pathological diagnosis of hepatocellular carcinoma

Minimally Invasive Interventional Center of Oncology, Beijing You An Hospital, Capital Medical University

摘要

摘要: 目的评价血清甲胎蛋白（AFP）及维生素K缺乏或拮抗剂Ⅱ诱导蛋白（PIVKA-Ⅱ）在肝细胞癌（HCC）病理诊断中的价值。方法回顾性研究2016年5月-12月于北京佑安医院肿瘤微创介入中心行超声引导下肝穿刺活组织检查的肝恶性肿瘤患者134例,其中术后病理证实为HCC患者103例,非HCC患者31例,对其血清AFP和PIVKA-Ⅱ的检测结果进行统计分析。2组间比较采用两独立样本秩和检验（Mann Whitney U检验）。采用Spearman秩相关检验分析AFP及PIVKA-Ⅱ的相关性,采用受试者工作特征曲线（ROC曲线）分析AFP及PIVKA-Ⅱ诊断HCC的效能,计算敏感度、特异度及ROC曲线下面积（AUC）,AUC比较应用Z检验。结果 HCC组血清AFP和PIVKA-Ⅱ水平均明显高于非HCC组（P值均<0.001）;血清AFP诊断HCC的AUC为0.842,PIVKA-Ⅱ诊断HCC的AUC为0.863,二者联合诊断AUC为0.869,三者间差异均有统计学意义（P值均<0.001）。血清AFP单独诊断HCC的敏感度为70.9%,特异度为90.3%;PIVKA-Ⅱ单独诊断HCC的...
- 甲胎蛋白类 /
- 维生素K缺乏或拮抗剂Ⅱ诱导蛋白 /
- 癌,肝细胞 /
- 诊断
Abstract: Objective To investigate the value of serum alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-Ⅱ) in the pathological diagnosis of hepatocellular carcinoma (HCC) .Methods A retrospective analysis was performed for the clinical data of 134 patients with malignant liver tumors who underwent ultrasound-guided liver biopsy in Minimally Invasive Interventional Center of Oncology, Beijing You An Hospital, from May 2016 to December 2016, and among these patients, 103 had pathologically confirmed HCC and 31 did not have HCC.A statistical analysis was performed for the measurements of serum AFP and PIVKA-Ⅱ.The Mann Whitney U test was used for comparison between two groups.The Spearman rank correlation analysis was used to analysis the correlation between AFP and PIVKA-Ⅱ.The ROC curve was used to evaluate the efficiency of AFP and PIVKA-Ⅱ in the diagnosis of HCC in patients with malignant liver tumors.Sensitivity and specificity were calculated, and the area under the ROC curve (AUC) was calculated.The Z test was used for the comparison of AUC.Results The HCC group had significantly higher serum levels of AFP and PIVKA-Ⅱ than the non-HCC group (all P<0.001) .Serum AFP had an AUC of 0.842 in the diagnosis of HCC, PIVKA-Ⅱ had an AUC of 0.863, and combined determination of AFP and PIVKA-Ⅱ had an AUC of 0.869;there was a significant difference in AUC between them (all P<0.001) .Serum AFP alone had a sensitivity of 70.9% and a specificity of 90.3%, PIVKA-Ⅱ alone had a sensitivity of 72.8% and a specificity of 77.4%, and combined determination of AFP and PIVKA-Ⅱ had a sensitivity of 82.5% and a specificity of 77.4%.In HCC patients, serum AFP was significantly correlated with PIVKA-Ⅱ (r=0.207, P<0.05) .Conclusion Serum AFP and PIVKA-Ⅱ have a high clinical value in the differential diagnosis of HCC in patients with malignant liver tumors.PIVKA-Ⅱ measured alone has a higher efficiency than AFP, and serum AFP and PIVKA-Ⅱ measured in combination have a higher efficiency than AFP or PIVKA-Ⅱ measured alone.Serum AFP and PIVKA-Ⅱ can provide a basis for preliminary judgment of pathological type in patients who refuse to undergo liver biopsy and help with the selection of standard therapeutic regimens and evaluation of clinical prognosis.
- alpha-Fetoproteins /
- protein induced by vitamin K absence or antagonist-Ⅱ /
- carcinoma, hepatocellular /
- diagnosis

HTML全文

参考文献(11)

[1] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.

[2]KIM DY, PAIK YH, AHN SH, et al.PIVKA-II is a useful tumor marker for recurrent hepatocelluar carcinoma after surgical resection[J].Oncology, 2007, 72 (Suppl 1) :52-57.

[3]YANG JJ, WANG P, YANG JZ, et al.Value of contrast-enhanced ultrasonography in diagnosis of intrahepatic cholangiocarcinoma[J].Chin J Med Offic, 2017, 45 (9) :981-982. (in Chinese) 杨金君, 王萍, 杨建忠, 等.超声造影对肝内胆管细胞癌诊断价值[J].临床军医杂志, 2017, 45 (9) :981-982.

[4]Pattern of serumα-fetal protein, intereleukin-6 and Golgi protein73 expressed in liver diseases and their diagnostic value on hepatocellular carcinoma[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2017, 11 (4) :339-344. (in Chinese) 张小曼, 魏梅娟, 许正锯, 等.血清甲胎蛋白、白细胞介素-6和高尔基体蛋白73在肝脏疾病中的表达特点及其对肝细胞癌的诊断价值[J/CD].中华实验和临床感染病杂志:电子版, 2017, 11 (4) :339-344.

[5]FORNER A, LLOVET JM, BRUIX J.Hepatocellular carcinoma[J].Lancet, 2012, 379 (9822) :1245-1255.

[6]DURAZO FA, BLATT LM, COREY WG, et al.Des-gammacarboxy prothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma[J].JGastroenterol Hepatol, 2008, 23 (10) :1541-1548.

[7]ERTLE JM, HEIDER D, WICHERT M, et al.A combination ofα-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatoeellular carcinoma[J].Digestion, 2013, 87 (2) :121-131.

[8]HUANG SJ, JIANG FF, WANG Y, et al.Diagnostic value of joint detection of AFP and PIVKA-II in hepatocellular carcinoma[J].Labeled Immunoassay Clin Med, 2016, 23 (10) :1134-1138.黄述婧, 姜菲菲, 王颖, 等.AFP与PIVKA-Ⅱ联合检测在原发性肝癌诊断中的应用研究[J].标记免疫分析与临床, 2016, 23 (10) :1134-1138.

[9]JI WB, XIAO NJ, LUO Y, et al.Alpha-fetoprotein and desgamma-carboxyprothrombin in the differential diagnosis of hepatocellular carcinoma from other liver tumors[J].Chin J Hepatobiliary Surg, 2016, 22 (3) :145-149. (in Chinese) 纪文斌, 肖年军, 罗英, 等.甲胎蛋白与异常凝血酶原在鉴别诊断肝细胞癌中的价值[J].中华肝胆外科杂志, 2016, 22 (3) :145-149.

[10]ZHANG YS, CHU JH, CUI SX, et al.Des-γ-carboxy prothrombin (DCP) as a potential autologous growth factor for the development of hepatocellular carcinoms[J].Cell Physiol Biochem, 2014, 34 (3) :903-915.

[11]ZINKIN NT, GRALL F, BHASKAR K, et al.Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease[J].Clin Cancer Res, 2008, 14 (2) :470-477.

施引文献

资源附件(0)

访问统计